Processa Pharmaceuticals Inc
PCSA0.320USD
-0.026-7.63%
交易中 （美東）報價延遲15分鐘
12.87M總市值
虧損本益比TTM
關於 Processa Pharmaceuticals Inc 公司
Processa Pharmaceuticals, Inc. 是一家臨牀階段的生物製藥公司。該公司專注於利用其監管科學方法，包括與食品和藥物管理局 (FDA) 的 Project Optimus Oncology 計劃和相關的 FDA 指導草案相關的原則，開發下一代化療 (NGC) 腫瘤藥物產品。其正在研發的三種 NGC 治療藥物是 NGC-卡培他濱 (NGC-Cap)、PCS3117（也稱爲 NGC-吉西他濱 (NGC-Gem)）和 PCS11T（也稱爲 NGC-伊立替康 (NGC-Iri)）。NGC-Cap 是 PCS6422 和卡培他濱的組合，卡培他濱是抗癌藥物 5-氟尿嘧啶的口服前體藥物。 PCS3117 是吉西他濱的口服類似物，通過與吉西他濱不同的酶系統轉化爲其活性代謝物，導致吉西他濱患者和一些對吉西他濱治療有抵抗力的患者產生積極反應。PCS11T 是伊立替康 (SN-38) 活性代謝物的前體藥物。
Processa Pharmaceuticals Inc簡介
公司代碼PCSA
公司名稱Processa Pharmaceuticals Inc
上市日期Oct 07, 2013
CEOMr. George K. Ng
員工數量10
證券類型Ordinary Share
年結日Oct 07
公司地址601 21St Street, Suite 300
城市VERO BEACH
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編32960
電話14437763133
網址https://www.processapharmaceuticals.com/
公司代碼PCSA
上市日期Oct 07, 2013
CEOMr. George K. Ng
Processa Pharmaceuticals Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. David Young, Ph.D.
Dr. David Young, Ph.D.
President - Research and Development, Director
President - Research and Development, Director
236.18K
+5.32%
Mr. George K. Ng
Mr. George K. Ng
Chief Executive Officer, Director
Chief Executive Officer, Director
107.20K
-28.91%
Mr. Patrick Lin
Mr. Patrick Lin
Chief Business and Strategy Officer
Chief Business and Strategy Officer
103.98K
+10.25%
Mr. Justin W. Yorke
Mr. Justin W. Yorke
Independent Chairman of the Board
Independent Chairman of the Board
53.57K
--
Dr. Sian Bigora, Pharm.D.
Dr. Sian Bigora, Pharm.D.
Chief Development Officer and Regulatory Officer, Founder
Chief Development Officer and Regulatory Officer, Founder
33.63K
+53.70%
Ms. Wendy Guy
Ms. Wendy Guy
Founder, Chief Administrative Officer
Founder, Chief Administrative Officer
26.34K
+122.14%
Ms. Geraldine Pannu
Ms. Geraldine Pannu
Independent Director
Independent Director
2.88K
--
Mr. Khoso Baluch
Mr. Khoso Baluch
Independent Director
Independent Director
1.40K
--
Mr. Russell L. Skibsted
Mr. Russell L. Skibsted
Chief Financial Officer
Chief Financial Officer
--
--
Mr. James R. (Jim) Neal
Mr. James R. (Jim) Neal
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. David Young, Ph.D.
Dr. David Young, Ph.D.
President - Research and Development, Director
President - Research and Development, Director
236.18K
+5.32%
Mr. George K. Ng
Mr. George K. Ng
Chief Executive Officer, Director
Chief Executive Officer, Director
107.20K
-28.91%
Mr. Patrick Lin
Mr. Patrick Lin
Chief Business and Strategy Officer
Chief Business and Strategy Officer
103.98K
+10.25%
Mr. Justin W. Yorke
Mr. Justin W. Yorke
Independent Chairman of the Board
Independent Chairman of the Board
53.57K
--
Dr. Sian Bigora, Pharm.D.
Dr. Sian Bigora, Pharm.D.
Chief Development Officer and Regulatory Officer, Founder
Chief Development Officer and Regulatory Officer, Founder
33.63K
+53.70%
Ms. Wendy Guy
Ms. Wendy Guy
Founder, Chief Administrative Officer
Founder, Chief Administrative Officer
26.34K
+122.14%
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 10月30日 週四
更新時間: 10月30日 週四
持股股東
股東類型
持股股東
持股股東
佔比
HX Entertainment Ltd
10.86%
Young (David)
0.47%
Ng (George K)
0.21%
Virtu Americas LLC
0.21%
Lin (Patrick)
0.21%
其他
88.05%
持股股東
持股股東
佔比
HX Entertainment Ltd
10.86%
Young (David)
0.47%
Ng (George K)
0.21%
Virtu Americas LLC
0.21%
Lin (Patrick)
0.21%
其他
88.05%
股東類型
持股股東
佔比
Corporation
10.94%
Individual Investor
1.14%
Investment Advisor
0.30%
Research Firm
0.25%
Investment Advisor/Hedge Fund
0.10%
Hedge Fund
0.09%
其他
87.18%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
39
371.61K
0.74%
+38.84K
2025Q2
48
5.43M
20.63%
+4.60M
2025Q1
51
708.86K
10.77%
+202.96K
2024Q4
53
384.33K
11.96%
-82.26K
2024Q3
54
333.95K
11.36%
-132.80K
2024Q2
56
390.99K
14.35%
-120.98K
2024Q1
59
435.26K
19.04%
+41.69K
2023Q4
57
343.21K
27.89%
+52.02K
2023Q3
57
335.15K
27.25%
+38.59K
2023Q2
52
272.47K
22.21%
-24.89K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
HX Entertainment Ltd
5.47M
10.86%
+5.47M
--
Aug 05, 2025
Young (David)
236.18K
0.47%
+11.93K
+5.32%
Aug 07, 2025
Ng (George K)
107.20K
0.21%
-43.60K
-28.91%
Aug 07, 2025
Virtu Americas LLC
104.72K
0.21%
+61.49K
+142.25%
Jun 30, 2025
Lin (Patrick)
103.98K
0.21%
+9.67K
+10.25%
Aug 07, 2025
UBS Financial Services, Inc.
64.61K
0.13%
+64.61K
--
Jun 30, 2025
Yorke (Justin W)
53.57K
0.11%
--
--
Aug 07, 2025
Alpine Global Management, LLC
53.42K
0.11%
+53.42K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
50.57K
0.1%
+16.16K
+46.96%
Jun 30, 2025
Cubist Systematic Strategies, LLC
41.85K
0.08%
+41.85K
--
Jun 30, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Jan 18, 2024
Merger
20→1
Jan 18, 2024
Merger
20→1
Jan 18, 2024
Merger
20→1
Jan 18, 2024
Merger
20→1
公告日期
類型
比率
Jan 18, 2024
Merger
20→1
Jan 18, 2024
Merger
20→1
Jan 18, 2024
Merger
20→1
Jan 18, 2024
Merger
20→1
